Method for analyzing related substances in fequesetide preparation

MYPI2025002631A0Undetermined Publication Date: 2024-02-02ZHAOKE (GUANGZHOU) OPHTHALMOLOGY PHARMACEUTICAL LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025002631
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2022-08-02
Filing Date
2023-05-12
Publication Date
2024-02-02

AI Technical Summary

Technical Problem

When the existing technology detects impurities in hair-growing peptides, the detection time is long, the specificity of multiple impurities is not good, and the impurity separation is poor. In particular, the impurities after the main peak cannot achieve baseline separation, which affects the detection efficiency and accuracy.

Method used

Using high-performance liquid chromatography, the detection was shortened by optimizing the liquid chromatography conditions, including using a chromatographic column with octadecylsilane bonded silica gel as the filler, and the mobile phase being a gradient elution of trifluoroacetic acid aqueous solution and trifluoroacetic acid acetonitrile. time and improve the separation of impurities.

Benefits of technology

It has achieved efficient separation and detection of impurities in hair-growing peptides, shortened the detection time to about 20 minutes, improved the separation of impurity peaks and the accuracy of purity detection, and established the quality standard of hair-growing peptides.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure PI2025002631_DRAWING_001
    Figure PI2025002631_DRAWING_001
  • Figure PI2025002631_DRAWING_002
    Figure PI2025002631_DRAWING_002
  • Figure PI2025002631_DRAWING_003
    Figure PI2025002631_DRAWING_003
Patent Text Reader

Abstract

A method for analyzing related substances in a biotinoyl tripeptide-1 preparation. In the method, high-performance liquid chromatography is used for determination, wherein the chromatographic column used therein is a YMC-Triart C18 chromatographic column, 4.6 × 150 mm, 3 μm; the column temperature is 35°C; the sample size is 100 mL; the detection wavelength is 210 nm; the mobile phase A is a 0.1% aqueous trifluoroacetic acid; the mobile phase B is 0.1% trifluoroacetic acid-acetonitrile; and gradient elution is used, and the elution program is as follows: at 0 min: the volume ratio of the mobile phase A to the mobile phase B is 100:0; at 8-13 min: the volume ratio of the mobile phase A to the mobile phase B is 85:15; and from 13 min to 20 min: the volume ratio of the mobile phase A to the mobile phase B is 100:0. In the present analysis method, the degree of separation between a main peak and impurity peaks is good, the peak pattern, tailing and number of theoretical plates are good, and the detection time is short; therefore, an effective method is provided for formulating quality standards for products of this type. Fig 7.
Need to check novelty before this filing date? Find Prior Art

Description

A method for analyzing related substances in hair growth peptide preparations Technical Field

[0001] The present invention relates to the field of analytical chemistry, and in particular to an analytical method for related substances in a hair growth peptide preparation. Background Art

[0002] Discovered by scientists at the National Institutes of Health (NIH), thymosin is the core functional region of thymosin Tβ4 that binds to actin. It consists of seven amino acids, following the sequence Leucine-Lysine-Lysine-Threonine-Glutamic Acid-Threonine-Glutamine (LKKTETQ). Studies have shown that thymosin has multiple functions, including binding to actin, promoting hair growth, stimulating angiogenesis, accelerating epidermal wound healing, and promoting cell migration.

[0003] The results of pharmacodynamic and safety evaluation tests showed that the peptide is safe and non-toxic, and it promotes corneal epithelial repair and reduces inflammatory responses in rats. The peptide eye drops are indicated for treating punctate corneal epithelial defects caused by dry eye and flake defects caused by various causes (including first- and second-degree burns, mechanical injuries, and iatrogenic causes).

[0004] During the synthesis process of hair-growing peptides, diastereomers, deletion peptides, insertion peptides, etc. were generated. Seven diastereomers of all single sites were obtained (among which the diastereomer of Thr was a D-allo structure), as well as 6 easily produced deletion peptide impurities, 13 insertion peptide impurities, 7 misconnected peptide impurities, and 10 broken peptide impurities. At the same time, according to its sequence structure and process, the IM020 / Glu7 impurity that was easily degraded was synthesized, and a total of 44 impurities were studied.

[0005] There is currently no testing method for APIs in the Chinese Pharmacopoeia. The testing method provided by Zhejiang Paipi Biotechnology Co., Ltd., a hair growth peptide manufacturer, is:

[0006] Chromatographic column: YMC-PackODS-AQ 4.6×250mm, 3μm (C18 high-efficiency chromatographic column produced by YMC, Japan)

[0007] Column temperature: 45°C

[0008] Mobile phase A: 50 mM phosphate buffer (pH 6.0) Mobile phase B: 50% methanol

[0009] Flow rate: 0.8ml / min

[0010] Injection volume: 20ul (2mg / ml)

[0011] Detection wavelength: UV210nm

[0012] Elution gradient:

[0013] As shown in Figures 1-3, Figure 1 is a spectrum of the detection of hair growth peptide in the prior art, and Figure 2 is a spectrum of the API and impurity A (Glu in the hair growth peptide in the prior art. 7 -hair-growing peptide) spectrum, FIG3 is the spectrum of API and impurity B (D-Leu 1 -hair growth peptide) and impurity C (Di-Glu 5 The above detection method has the following problems: the detection time is as long as 50 minutes, which affects the detection efficiency. The specificity of detecting multiple impurities simultaneously is poor, the separation of impurities from the main peak is poor, and after mixed standard detection, the separation of the first two impurities is very poor (far less than 1.5). Moreover, the impurities after the main peak cannot be baseline separated at all, making it impossible to detect multiple known impurities simultaneously. Therefore, a new purity detection method is needed to detect and separate these multiple known impurities and other unknown impurities.

[0014] Therefore, it is necessary to develop an analytical detection method that can effectively separate the related substances in hair growth peptides and eliminate the interference of excipients.

[0015] Summary of the Invention

[0016] The inventors of this invention developed multiple liquid chromatography conditions for the separation of impurities in hair growth peptides. Through process research, they ultimately identified a process that can fully control these impurities. This application optimizes the method for detecting several common impurities.

[0017] The present invention provides a method for efficiently analyzing related substances in hair growth peptides and greatly shortening the analysis time. The analysis method comprises a sample preparation step and a detection process using high performance liquid chromatography; the high performance liquid chromatography column method uses a chromatographic column with octadecylsilane bonded silica gel as a filler.

[0018] Furthermore, the analytical method can effectively separate the hair growth peptide from related impurities. Preferably, the related substances are Glu 7 -Hair growth peptide (impurity A), D-Leu 1 -Hair growth peptide (Impurity B) and Di-Glu 5 -Hair growth peptide (Impurity C).

[0019] Further, the mobile phase of the high pressure liquid chromatography column method includes mobile phase A and mobile phase B, wherein mobile phase A is a trifluoroacetic acid aqueous solution, wherein the volume ratio of trifluoroacetic acid to water is 0.05:100 to 0.15:100, for example, it can also be 0.06:100, 0.07:100, 0.08:100, 0.09:100, 0.10:100, 0.11:100, 0.12:100, 0.13:100, 0.14:100. Preferably, the volume ratio of trifluoroacetic acid to water in mobile phase A is 0.1:100.

[0020] Further, the mobile phase B is trifluoroacetic acid-acetonitrile, wherein the volume ratio of trifluoroacetic acid to acetonitrile is 0.05:100 to 0.15:100. For example, it can also be 0.06:100, 0.07:100, 0.08:100, 0.09:100, 0.10:100, 0.11:100, 0.12:100, 0.13:100, or 0.14:100. Preferably, the volume ratio of trifluoroacetic acid to acetonitrile in mobile phase B is 0.1:100.

[0021] Furthermore, the high pressure liquid chromatography detection wavelength is 200 nm to 220 nm, for example, it can also be 201 nm, 202 nm, 203 nm, 204 nm, 205 nm, 206 nm, 207 nm, 208 nm, 209 nm, 210 nm, 211 nm, 212 nm, 213 nm, 214 nm, 215 nm, 216 nm, 217 nm, 218 nm, 219 nm. Preferably, the detection wavelength is 210 nm;

[0022] Furthermore, the column temperature of the chromatographic column is 30-40° C., for example, 31° C., 32° C., 33° C., 34° C., 35° C., 36° C., 37° C., 38° C., or 39° C. Preferably, the temperature of the chromatographic column is 35° C.

[0023] Furthermore, the injection volume for HPLC is 90-110 μl, for example, 91 μl, 92 μl, 93 μl, 94 μl, 95 μl, 96 μl, 97 μl, 98 μl, 99 μl, 100 μl, 101 μl, 102 μl, 103 μl, 104 μl, 105 μl, 106 μl, 107 μl, 108 μl, or 109 μl. Preferably, the injection volume is 100 μl.

[0024] Furthermore, the flow rate of the high pressure liquid chromatography is 0.8-1.5 ml / min, for example, it can be 0.8 ml / min, 0.9 ml / min, 1.0 ml / min, 1.1 ml / min, 1.2 ml / min, 1.3 ml / min, 1.4 ml / min, 1.5 ml / min, preferably, the flow rate is 0.8 ml / min.

[0025] Preferably, the specifications of the chromatographic column are 4.6×150 mm, 3 μm.

[0026] Furthermore, the chromatographic column is selected from one of a Waters chromatographic column, an Agilent chromatographic column, a Thermo chromatographic column, a Phenomenex chromatographic column, a Shimatsu chromatographic column or a YMC chromatographic column. In a specific embodiment, the chromatographic column is a YMC-Triart C18.

[0027] Furthermore, the high pressure liquid chromatography method adopts gradient elution, and the procedure of the gradient elution is:

[0028] 0 min: the volume ratio of mobile phase A to mobile phase B is 100:0;

[0029] 8 min: the volume ratio of mobile phase A to mobile phase B is 83:17 to 87:13;

[0030] 8 min to 13 min: the volume ratio of mobile phase A to mobile phase B was maintained at 83:17 to 87:13;

[0031] After 13 min until 20 min: the volume ratio of mobile phase A to mobile phase B was 100:0.

[0032] Preferably, the procedure of the gradient elution is:

[0033] 0 min: the volume ratio of mobile phase A to mobile phase B is 100:0;

[0034] 8 min: The volume ratio of mobile phase A to mobile phase B was maintained at 85:15;

[0035] 8 min to 13 min: the volume ratio of mobile phase A to mobile phase B was maintained at 85:15;

[0036] After 13 min until 20 min: the volume ratio of mobile phase A to mobile phase B was 100:0.

[0037] In one embodiment, the elution procedure is as follows:

[0038] Furthermore, in some specific embodiments requiring quantification, the method further comprises calculating the integrated area of ​​the peak.

[0039] The second aspect of the present invention provides an application of the aforementioned analytical method in the quality control of hair growth peptide preparations.

[0040] In some embodiments, the application includes detecting the purity of the germinative peptide, analyzing the impurity types and / or purity of the germinative peptide.

[0041] In a specific embodiment, the hair growth peptide preparation is hair growth peptide eye drops.

[0042] The method of the present invention uses amino acid / peptide type octadecylsilane bonded silica gel as a filler (4.6×150 mm, 3 μm), and the mobile phase is: A: ultrapure water (0.1% trifluoroacetic acid); B: acetonitrile (0.1% trifluoroacetic acid); the detection wavelength is 210 nm, the column temperature is 35°C, and the flow rate is 0.8-1.5 ml / min. It can effectively detect and separate the three known impurities of the germination peptide (Glu7-germination peptide, D-Leu 1 -Hair growth peptide and Di-Glu 5 -hair-growing peptide) and shortened the detection time to about 20 minutes, thereby establishing the quality standard of hair-growing peptide. BRIEF DESCRIPTION OF THE DRAWINGS

[0043] FIG1 is a spectrum of the detection of hair growth peptides in the prior art;

[0044] FIG2 is a spectrum of API and related substances in the hair growth peptide in the prior art;

[0045] FIG3 is a spectrum of API and other related substances in the hair growth peptide in the prior art;

[0046] FIG4 is a spectrum under the optimized conditions of Example 1;

[0047] FIG5 is a spectrum of isocratic elution of Example 2;

[0048] FIG6 is a spectrum of Example 3 after reducing the injection amount;

[0049] FIG7 is a spectrum after enhanced gradient elution in Example 4. DETAILED DESCRIPTION

[0050] The present invention discloses a method for analyzing related substances in hair-growing peptide preparations. Those skilled in the art can refer to the content of this document and appropriately modify the process parameters to implement the method. It is particularly important to note that all similar substitutions and modifications that would be obvious to those skilled in the art are considered to be included in the present invention. The method of the present invention has been described through preferred embodiments. It is obvious that those skilled in the art can modify or appropriately alter and combine the methods and applications described herein to implement and apply the technology of the present invention without departing from the content, spirit, and scope of the present invention.

[0051] Unless otherwise defined, all scientific and technical terms used in the present invention have the same meanings as commonly understood by one of ordinary skill in the art to which the present invention relates.

[0052] In the present invention, the term "mobile phase" refers to the substance that carries the components to be analyzed forward during the chromatography process. The mobile phase is the other phase in equilibrium with the stationary phase that drives the sample forward.

[0053] In order to enable those skilled in the art to better understand the technical solutions of the present invention, the present invention is further described in detail below with reference to specific embodiments.

[0054] In the following examples, the hair growth peptide was obtained from Zhejiang Paipeptide Biological Co., Ltd. with batch number PT2021122101, water was ultrapure water, and other reagents were of analytical grade.

[0055] Example 1:

[0056] Prepare the hair growth peptide eye drops as follows:

[0057] 1) Add about 70% of the prescribed amount of water for injection into a certain capacity dispensing tank;

[0058] 2) Add the prescribed amount of inorganic salt into a stainless steel barrel, add about 15% of the prescribed amount of water for injection, and stir to dissolve; add the prescribed amount of hair growth peptide, and stir to dissolve until a clear solution is obtained;

[0059] 3) Transfer the mixed solution to a 25L dispensing tank and rinse the container containing the mixed solution three times with about 10% of the prescribed amount of water for injection. Add the rinse solution to the dispensing tank and stir for 5 minutes to mix evenly.

[0060] 4) Take an appropriate amount of hydrochloric acid and slowly add it to cooled water for injection to prepare a 1 mol / L hydrochloric acid solution for later use;

[0061] 5) Turn on stirring and slowly add the prepared hydrochloric acid solution while stirring to adjust the pH to 6.5-7.5. Continue stirring for 5 minutes.

[0062] 6) Add water for injection to the full volume of the prescription, start stirring, and stir for 10 minutes to ensure a uniform mixture. Take a sample for testing.

[0063] Octadecylsilane bonded silica gel was used as the chromatographic column filler.

[0064] Chromatographic conditions:

[0065]

Instrument

[0066]

Detector

[0067] Mobile phase A: 0.1% trifluoroacetic acid in water

[0068] Mobile phase B: 0.1% trifluoroacetic acid in acetonitrile

[0069] Chromatographic column: YMC-Triart C18 4.6×150mm, 3μm

[0070] Column temperature 35 °C, injection volume 100 μl, detection wavelength 210 nm, flow rate 0.8 ml / min

[0071] Perform gradient elution according to Table 1:

[0072] Table 1: Elution program

[0073] The results are shown in Figure 4. In this method, the separation between the main peak of the hair growth peptide and the impurity peak is good (2.5), and the peak shape, tailing (1.1) and theoretical plate number (13,000) can all be optimized. The injection time is greatly shortened to 20 minutes, and the main peak has a good peak shape, a small tailing factor, and good separation from the impurity peak.

[0074] Example 2: Changing the chromatographic column based on the original chromatographic conditions and adjusting the elution gradient to isocratic elution

[0075] Chromatographic conditions:

[0076] Mobile phase A: 0.1% trifluoroacetic acid in water

[0077] Mobile phase B: 0.1% trifluoroacetic acid in acetonitrile

[0078] Chromatographic column: Agilent Zorbax SB-C18 column, 4.6×150 mm, 5 μm

[0079] Column temperature 35°C, injection volume 100 μl, wavelength 210 nm, flow rate 0.8 ml / min

[0080] The elution gradient was adjusted to isocratic elution (mobile phase A:B = 90:10), and the elution time was 30 minutes. The isocratic elution of the main peak was observed at a 10% organic phase ratio. As shown in Figure 5, under all three gradient conditions, impurity peaks appeared at the peak position of the main peak of the hair growth peptide, indicating low resolution. This demonstrates that under isocratic elution conditions, the resolution between the main peak and impurity peaks is poor, and at low organic phase ratios, the main peak tails severely.

[0081] Example 3: Reduce the injection volume to 50 μl and continue to investigate the elution gradient

[0082] Chromatographic conditions:

[0083] Mobile phase A: 0.1% trifluoroacetic acid in water

[0084] Mobile phase B: 0.1% trifluoroacetic acid in acetonitrile

[0085] Chromatographic column: YMC-Triart C18 4.6×150mm, 3μm

[0086] Column temperature 35 °C, injection volume 50 μl, wavelength 210 nm, flow rate 0.8 ml / min

[0087] In the first 3 minutes of elution, a high proportion of aqueous phase was used to elute the excipient peak with greater polarity. From 3 to 15 minutes, a 7% organic phase ratio was used to elute the main peak. The peak shape of the main peak and the separation from the impurity peak were observed. The main peak was ensured to be unaffected by the gradient change. Gradient elution was performed according to Table 2:

[0088] Table 2: Elution program

[0089] The investigation results are shown in Figure 6. The main peak is greatly disturbed by the gradient change peak.

[0090] Example 4: Increasing the gradient change rate and observing the separation of the main peak and impurity peaks

[0091] Chromatographic conditions:

[0092] Mobile phase A: 0.1% trifluoroacetic acid in water

[0093] Mobile phase B: 0.1% trifluoroacetic acid in acetonitrile

[0094] Chromatographic column: YMC-Triart C18 4.6×150mm, 3μm

[0095] Column temperature 35°C, injection volume 100 μl, wavelength 210 nm, flow rate 0.8 ml / min

[0096] Perform gradient elution according to Table 3:

[0097] Table 3: Elution program

[0098] The results are shown in Figure 7. The separation degree between the main peak of the hair growth peptide and the impurity peak in the test solution is poor (1.1).

[0099] The foregoing description is merely a preferred embodiment of the present invention and is not intended to limit the present invention. Those skilled in the art will readily appreciate that various modifications and variations of the present invention are possible. Any modifications, equivalent substitutions, or improvements made within the spirit and principles of the present invention are intended to be within the scope of protection of the present invention.

Claims

1. A method for analyzing related substances in a hair growth peptide preparation, characterized in that: The analytical method comprises the following steps: (1) Prepare samples; (2) Detection is performed using high performance liquid chromatography; wherein the high performance liquid chromatography column method uses a chromatographic column with octadecylsilane bonded silica gel as a filler; the mobile phase of the high performance liquid chromatography column method includes mobile phase A and mobile phase B, wherein mobile phase A is a trifluoroacetic acid aqueous solution, wherein the volume ratio of trifluoroacetic acid to water is 0.05:100 to 0.15:100, and mobile phase B is trifluoroacetic acid-acetonitrile.

2. The method for analyzing related substances in the hair growth peptide preparation according to claim 1, characterized in that: The volume ratio of trifluoroacetic acid to acetonitrile in the mobile phase B is 0.05:100 to 0.15:

100.

3. The method for analyzing related substances in the hair growth peptide preparation according to claim 1, characterized in that: The column temperature of the chromatographic column is 30-40°C.

4. The method for analyzing related substances in the hair growth peptide preparation according to claim 1, characterized in that: The injection volume for HPLC was 90-110 μl.

5. The method for analyzing related substances in the hair growth peptide preparation according to claim 1, characterized in that: The detection wavelength in the high pressure liquid chromatography is 210 nm.

6. The method for analyzing related substances in the hair growth peptide preparation according to claim 1, characterized in that: The chromatographic column is selected from one of a Waters chromatographic column, an Agilent chromatographic column, a Thermos chromatographic column, a Phenomenex chromatographic column, a Shimatsu chromatographic column or a YMC chromatographic column.

7. The method for analyzing related substances in the hair growth peptide preparation according to claim 1, characterized in that: The specifications of the chromatographic column are 4.6×150 mm, 3 μm.

8. The method for analyzing related substances in the hair growth peptide preparation according to claim 1, characterized in that: The high pressure liquid chromatography method adopts gradient elution, and the procedure of the gradient elution is: 0 min: the volume ratio of mobile phase A to mobile phase B is 100:0; 8 min: the volume ratio of mobile phase A to mobile phase B is 83:17 to 87:13; 8 min to 13 min: the volume ratio of mobile phase A to mobile phase B is 83:17 to 87:13; After 13 min until 20 min: the volume ratio of mobile phase A to mobile phase B was 100:

0.

9. The method for analyzing related substances in the hair growth peptide preparation according to claim 1, characterized in that: The high pressure liquid chromatography method adopts gradient elution, and the procedure of the gradient elution is: 0 min: the volume ratio of mobile phase A to mobile phase B is 100:0; 8 min: the volume ratio of mobile phase A to mobile phase B is 85:15; 8 min to 13 min: the volume ratio of mobile phase A to mobile phase B is 85:15; After 13 min until 20 min: the volume ratio of mobile phase A to mobile phase B was 100:

0.

10. Use of the analytical method for related substances in the hair-growing peptide preparation according to any one of claims 1 to 9 in the quality control of the hair-growing peptide preparation.